BR112013022011A2 - proteína da espícula do vírus da bronquite infecciosa ou um fragmento imunogênico da mesma, estrutura de proteína, molécula de dna, plasmídeo, vírus carreador recombinante vivo aviário, vacina, e, célula de mamífero - Google Patents

proteína da espícula do vírus da bronquite infecciosa ou um fragmento imunogênico da mesma, estrutura de proteína, molécula de dna, plasmídeo, vírus carreador recombinante vivo aviário, vacina, e, célula de mamífero

Info

Publication number
BR112013022011A2
BR112013022011A2 BR112013022011A BR112013022011A BR112013022011A2 BR 112013022011 A2 BR112013022011 A2 BR 112013022011A2 BR 112013022011 A BR112013022011 A BR 112013022011A BR 112013022011 A BR112013022011 A BR 112013022011A BR 112013022011 A2 BR112013022011 A2 BR 112013022011A2
Authority
BR
Brazil
Prior art keywords
vaccine
plasmid
virus
protein
dna molecule
Prior art date
Application number
BR112013022011A
Other languages
English (en)
Inventor
Carla Christina Schrier
Hélène Verheije
Original Assignee
Intervet Int Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Intervet Int Bv filed Critical Intervet Int Bv
Publication of BR112013022011A2 publication Critical patent/BR112013022011A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/215—Coronaviridae, e.g. avian infectious bronchitis virus
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5256—Virus expressing foreign proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/735—Fusion polypeptide containing domain for protein-protein interaction containing a domain for self-assembly, e.g. a viral coat protein (includes phage display)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/20011—Coronaviridae
    • C12N2770/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/20011—Coronaviridae
    • C12N2770/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
BR112013022011A 2011-03-02 2012-03-01 proteína da espícula do vírus da bronquite infecciosa ou um fragmento imunogênico da mesma, estrutura de proteína, molécula de dna, plasmídeo, vírus carreador recombinante vivo aviário, vacina, e, célula de mamífero BR112013022011A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161448464P 2011-03-02 2011-03-02
EP11156526 2011-03-02
PCT/EP2012/053493 WO2012117045A1 (en) 2011-03-02 2012-03-01 Infectious bronchitis virus (ibv) spike protein as subunit vaccine

Publications (1)

Publication Number Publication Date
BR112013022011A2 true BR112013022011A2 (pt) 2016-11-16

Family

ID=44344052

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112013022011A BR112013022011A2 (pt) 2011-03-02 2012-03-01 proteína da espícula do vírus da bronquite infecciosa ou um fragmento imunogênico da mesma, estrutura de proteína, molécula de dna, plasmídeo, vírus carreador recombinante vivo aviário, vacina, e, célula de mamífero

Country Status (4)

Country Link
US (1) US9597390B2 (pt)
EP (1) EP2681232A1 (pt)
BR (1) BR112013022011A2 (pt)
WO (1) WO2012117045A1 (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104885994A (zh) * 2015-05-04 2015-09-09 霍邱县科瑞达禽业有限公司 一种鸡群饮水免疫方法
US10329538B2 (en) 2017-01-27 2019-06-25 University Of Georgia Research Foundation, Inc. Live attenuated Arkansas serotype infectious bronchitis virus vaccine
US10772953B2 (en) * 2017-08-09 2020-09-15 Auburn University Recombinant spike ectodomain proteins, compositions, vectors, kits, and methods for immunizing against avian infectious bronchitis virus
CN115887634B (zh) * 2022-12-28 2023-08-01 武汉科前生物股份有限公司 鸡传染性支气管炎二价亚单位疫苗及应用

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2070997T3 (es) 1989-12-04 1995-06-16 Akzo Nobel Nv Virus de herpes recombinante de pavos y vacunas vector vivas derivadas de los mismos.
US6296852B1 (en) * 1993-04-14 2001-10-02 Commonwealth Scientific And Industrial Research Organisation Recombinant avian adenovirus vector
FR2714074B1 (fr) 1993-12-20 1996-03-01 Pasteur Institut Promoteurs des gènes GRA1, GRA2, GRA5 et GRA6 de toxoplasma gondii et vecteurs d'expression comprenant lesdits promoteurs.
WO1998049195A1 (en) 1997-04-29 1998-11-05 Universiteit Utrecht Corona virus-like particles as tools for vaccination and therapy
WO2001019958A2 (en) 1999-09-17 2001-03-22 Dana-Farber Cancer Institute, Inc. Stabilized soluble glycoprotein trimers
ES2170622B1 (es) 1999-12-03 2004-05-16 Consejo Superior De Investigaciones Cientificas Clones y vectores infectivos derivados de coronavirus y sus aplicaciones.
EP1241177A1 (en) 2001-03-15 2002-09-18 Akzo Nobel N.V. Recombinant infectious laryngotracheitis virus vaccine
US20050186575A1 (en) * 2001-05-17 2005-08-25 Rottier Petrus J.M. Corona-virus-like particles comprising functionally deleted genomes
MXPA03010427A (es) * 2001-05-17 2004-12-06 Univ Utrecht Particulas del tipo del virus corona que comprenden genomas funcionalmente eliminados.
EP1960525B1 (en) * 2005-09-09 2013-04-24 Zymogenetics, Inc. Method for preparing trimeric proteins
KR20080103602A (ko) 2006-03-15 2008-11-27 인터벳 인터내셔널 비.브이. 재조합 모노네가바이랄러스 바이러스 벡터
DK2294202T3 (en) * 2008-07-08 2015-08-31 Medicago Inc SOLUBLE RECOMBINANT INFLUENZA ANTIGENES
US8778003B2 (en) 2008-09-21 2014-07-15 Syneron Medical Ltd Method and apparatus for personal skin treatment
WO2010148434A1 (en) * 2009-06-22 2010-12-29 The Macfarlane Burnet Institute For Medical Research And Public Health Ltd Chimeric molecules
EP3988115A3 (en) * 2009-07-15 2022-08-17 GlaxoSmithKline Biologicals S.A. Rsv f protein compositions and methods for making same
US8043109B2 (en) 2009-07-27 2011-10-25 Avx Corporation Wire to board connector

Also Published As

Publication number Publication date
US9597390B2 (en) 2017-03-21
EP2681232A1 (en) 2014-01-08
US20140127264A1 (en) 2014-05-08
WO2012117045A1 (en) 2012-09-07

Similar Documents

Publication Publication Date Title
BR112013030963A2 (pt) proteína de fusão, polinucleotídio, constructo, vetor, célula hospedeira ou organismo, composição farmacêutica ou vacina, uso da proteína de fusão, método para prevenir ou tratar infecção hev ou doenças associadas com infecção hev, método para prevenir ou tratar infecção do vírus influenza e doenças associadas com a infecção do vírus influenza, método para melhorar a imunogenicidade de uma proteína alvo e uso de crm197 ou um fragmento do mesmo
BR112014009565A2 (pt) vírus da doença de marek não patogênico recombinante, ácido nucleico recombinante, vacina, e, método para ajudar na proteção de um frango contra vírus
BR112014014078A8 (pt) composições compreendendo constructos genéticos il-12 aperfeiçoados e vacinas, imunoterapêuticos e métodos de uso dos mesmos
EA201391109A1 (ru) Молекулы нуклеиновой кислоты, кодирующие новые антигены герпеса, вакцина, включающая их, и способы их использования
AR093377A1 (es) Anticuerpos anti-notch y conjugados de anticuerpo-farmaco
BR112014022788A2 (pt) peptídeo, polipeptídeos, ácido nucleico, composição farmacêutica, conjugado e método in vitro
BR112014010545A2 (pt) composição farmacêutica, método para tratar um paciente infectado com vírus da hepatite c, uso de uma composição
EA201390806A1 (ru) Конструкция пептидного каркаса
BR112013007486A2 (pt) vacinas de herpesvírus vetorizadas com vírus da doença de newcastle
BR112013015113A2 (pt) método de inativar um vírus contendo envelope lipídico, e, fator viii e proteína essencialmente livre de um vírus contendo envelope lipídico
EA201500643A1 (ru) Парвовирус свиней 5а, способы применения и вакцина
BR112012027151A2 (pt) diagnósticode infecções virais por detecção de dna viral, genômico e infeccioso por molecular combing
EA201001045A1 (ru) Модифицированный вирус гриппа
BR112012003837B8 (pt) Vacina de paramyxovírus aviária recombinante e método para fazer e usar a mesma
ZA201306009B (en) Nucleic acid molecule encoding hepatitis b virus core protein and vaccine comprising the same
BR112013022011A2 (pt) proteína da espícula do vírus da bronquite infecciosa ou um fragmento imunogênico da mesma, estrutura de proteína, molécula de dna, plasmídeo, vírus carreador recombinante vivo aviário, vacina, e, célula de mamífero
BR112013000031A2 (pt) proteína l1 hpv52 truncada ou variante da mesma, ácido nucleíco isolado, vetor, célula hospedeira, partícula do tipo viral hpv52, composição, composição farmacêutica ou vacina, método para obter uma proteína l1 hpv52 truncada, método para preparar a partícula do tipo viral hpv52, método para preparar uma vacina, método para prevenir a infecção hpv ou uma doença causada pela infecção de hpv e uso da proteína l1 hpv52 truncada ou variante da mesma
BR112013016503A2 (pt) composições e método de vacina de vírus da diarreia viral bovina tipo 1b.
MA37749B1 (fr) Vaccins contre les virus réassortis de la fièvre catarrhale et de la peste équine
PT2575872T (pt) Concentração de antigénios da vacina da gripe sem liofilização
EP2716752A4 (en) RECOMBINANT DOG INFLUENZA VIRUS, MANUFACTURING METHOD AND APPLICATION THEREOF
PH12015501721A1 (en) Porcine parvovirus 5b, methods of use and vaccine
HK1162599A1 (en) An infectious recombinant cloning system of duck enteritis virus vaccine strain, construction method and use thereof
BRPI1007584A2 (pt) vacina de sarampo-malária combinada, vetor de vírus de vacina de sarampo, hospedeiro e composição de vacina de sarampo-malária combinada
UY33523A (es) ?vectores de parapoxvirus?.

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 6A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]